1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1h -preparation of ethyl pyrazolo[3,4-c]pyridine-3-carboxylate_kain industrial additive
background and overview[1] 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetra hydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester is an intermediate for the preparation of apixaban, an antithrombotic drug produced by bristol-myers squibb in the united states. -the factor xa direct inhibitor jointly developed by bristol-myers squibb and pfizer was approved for marketing in the eu in march 2011, and the fda approved the drug…
